Infliximab 증량 투여 후 2주 내에 임상적 관해가 유도되었고 이후 관해가 유지되었으나 7개월에 CRP 수치 증가와 함께 임상적 재발 소견을 보여, azathioprine을 MTX 매주 25 mg 경구 투여로 변경하였다.
Clinical remission was induced within 2 weeks after infliximab increased dose administration, and the remission ended up being maintained thereafter, but clinical recurrence ended up being observed at 7 months with an increase in CRP amounts.